Rabbit Anti-CART, aa61-102 (Cocaine and Amphetamine-regulated Transcript Protein, CART Prepropeptide, CARTPT)
Applications
Suitable for use in ELISA. Other applications not tested.
Recommended Dilution
Optimal dilutions to be determined by the researcher.
AA Sequence
Lys-Tyr-Gly-Gln-Val-Pro-Met-Cys-Asp-Ala-Gly-Glu-Gln-Cys-Ala-Val-Arg-Lys-Gly-Ala-Arg-Ile-Gly-Lys-Leu-Cys-Asp-Cys-Pro-Arg-Gly-Thr-Ser-Cys-Asn-Ser-Phe-Leu-Leu-Lys-Cys-Leu [Disulfide Bridge: Cys8-Cys26 Cys14-Cys34 and Cys28-Cys41]
Storage and Stability
Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Immunogen
Synthetic peptide corresponding to aa61-102 of human CART.
Form
Supplied as a lyophilized powder. Reconstitute with PBS.
Purity
Purified by Protein A affinity chromatography.
Specificity
Recognizes human CART. Species crossreactivity: rat, mouse, bovine. %Cross-reactivity with Peptides: CART (61-102) (Human, Rat): 100%; CART (55-102) (Rat): 100%; Agouti-Related Protein 83-132-NH2 (Human): 2%; Leptin (Human): 0%; Neuropeptide (Human, Rat): 0%; a-MSH: 0%; Orexin A (Human, Mouse, Rat): 0%; Orexin B (Human): 0%
